Literature DB >> 7428785

Demonstration of inhibitory factors affecting cell-mediated immunity in patients with Hodgkin's disease.

M V Moghe, S H Advani, S G Gangal.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7428785     DOI: 10.1016/0014-2964(80)90332-1

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  6 in total

1.  Impairment in proliferation, lymphokine production and frequency distribution of mitogen-responsive and interleukin-2-producing cells in Hodgkin's disease.

Authors:  R N Damle; S H Advani; S G Gangal
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

2.  Lymphocyte subsets and natural killer cell responses during cytomegalovirus mononucleosis.

Authors:  C R Rinaldo; M Ho; W H Hamoudi; X E Gui; R L DeBiasio
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

3.  Affinity of IL-2 receptors and proliferation of mitogen activated lymphocytes in Hodgkin's disease.

Authors:  R N Damle; R J Tatake; S H Advani; S G Gangal
Journal:  Br J Cancer       Date:  1990-03       Impact factor: 7.640

4.  Natural killer and lymphokine activated killer cell functions in Hodgkin's disease.

Authors:  N Rajaram; R J Tatake; S H Advani; S G Gangal
Journal:  Br J Cancer       Date:  1990-08       Impact factor: 7.640

5.  Functional evaluation of T-lymphocytes from peripheral blood and spleens in Hodgkin's disease.

Authors:  R Mukhopadhyaya; S H Advani; S G Gangal
Journal:  Br J Cancer       Date:  1987-12       Impact factor: 7.640

6.  Cell mediated immunity in human pathology: the importance of choosing the right weapon.

Authors:  M Clerici; C Vismara; C Clerici; M L Villa
Journal:  Infect Dis Obstet Gynecol       Date:  1996
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.